Hepatectomy for hepatocellular carcinoma in the era of liver transplantation

World Journal of Gastroenterology

Volumn 20, Issue 28, 2014, Pages 9237-9244

  Lu, Wen Ping ^a   Dong, Jia Hong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Prognosis

Indexed keywords

CHLOROTRIANISENE; IODINATED POPPYSEED OIL; IODINE 131; YTTRIUM 90;

ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); EX VIVO STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; META ANALYSIS (TOPIC); PORTAL VEIN EMBOLIZATION; POSTOPERATIVE CARE; RADIOEMBOLIZATION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; SALVAGE THERAPY; SURGICAL APPROACH; WIDE EXCISION; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETREATMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; RETREATMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908868442     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i28.9237     Document Type: Article

References (56)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-676 [PMID: 14100514]
3. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200 [PMID: 15918147]
4. Poon RT. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection? Ann Surg Oncol 2007; 14: 541-547 [PMID: 17103069 DOI: 10.1245/s10434-006-9156-z]
5. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52 Suppl 3: iii1-iii8 [PMID: 12692148 DOI: 10.1136/gut.52.suppl-3.iii1]
6. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-486 [PMID: 11923602 DOI: 10.1097/00000658-200204000-00004]
7. Poston G, Adam R, Vauthey JN. Downstaging or downsizing: time for a new staging system in advanced colorectal cancer? J Clin Oncol 2006; 24: 2702-2706 [PMID: 16782909 DOI: 10.1200/JCO.2006.05.8404]
8. Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 2004; 240: 299-305 [PMID: 15273555 DOI: 10.1097/01.sla.0000133123.11932.19]
9. Lu WP, Dong JH, Huang ZQ. Surgical management for hepatocellular carcinoma. Zhonghua Putong Waike Zazhi 2008; 23: 555-557
10. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353: 797-801 [PMID: 10459961 DOI: 10.1016/S0140-6736(98)06475-7]
11. Heriot AG, Karanjia ND. A review of techniques for liver resection. Ann R Coll Surg Engl 2002; 84: 371-380 [PMID: 12484574 DOI: 10.1308/003588402760978148]
12. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-175 [PMID: 11167863 DOI: 10.1046/j.1365-2168.2001.01658.x]
13. Elias D, De Baere T, Roche A, Mducreux J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86: 784-788 [PMID: 10383579 DOI: 10.1046/j.1365-2168.1999.01154.x]
14. Hemming AW, Reed AI, Langham MR, Fujita S, van der Werf WJ, Howard RJ. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg 2002; 235: 850-858 [PMID: 12035042 DOI: 10.1097/00000658-200206000-00013]
15. Hemming AW, Reed AI, Langham MR, Fujita S, Howard RJ. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg 2004; 239: 712-79; discussion 712-79; [PMID: 15082976 DOI: 10.1097/01. sla.0000124387.87757.eb]
16. Pichlmayr R, Bretschneider HJ, Kirchner E, Ringe B, Lamesch P, Gubernatis G, Hauss J, Niehaus KJ, Kaukemüller J. [Ex situ operation on the liver. A new possibility in liver surgery]. Langenbecks Arch Chir 1988; 373: 122-126 [PMID: 3287072 DOI: 10.1007/BF01262775]
17. Oldhafer KJ, Lang H, Schlitt HJ, Hauss J, Raab R, Klempnauer J, Pichlmayr R. Long-term experience after ex situ liver surgery. Surgery 2000; 127: 520-527 [PMID: 10819060 DOI: 10.1067/msy.2000.105500]
18. Marín-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003; 47: 13-27 [PMID: 12853096 DOI: 10.1016/S1040-8428(02)00213-5]
19. Lü WP, Dong JH, Zhang WZ, Huang XQ, Wang SG, Bie P. [Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2008; 30: 386-392 [PMID: 18795607]
20. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009; 249: 617-623 [PMID: 19300227 DOI: 10.1097/SLA.0b013e31819ed22f]
21. Fisher ER, Turnbull RB. The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet 1955; 100: 102-108 [PMID: 13238159]
22. Roberts S, Watne A, Mcgrath R, Mcgrew E, Cole WH. Technique and results of isolation of cancer cells from the circulating blood. AMA Arch Surg 1958; 76: 334-346 [PMID: 13507823 DOI: 10.1001/archsurg.1958.01280210004002]
23. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, Blumgart LH. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187: 620-625 [PMID: 9849736 DOI: 10.1016/S1072-7515(98)00240-3]
24. Dixon E, Vollmer CM, Bathe OF, Sutherland F. Vascular occlusion to decrease blood loss during hepatic resection. Am J Surg 2005; 190: 75-86 [PMID: 15972177 DOI: 10.1016/j.amjsurg.2004.10.007]
25. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 10-24 [PMID: 10862190 DOI: 10.1097/00000658-200007000-00003]
26. Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P'eng FK. Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol 1997; 66: 122-126 [PMID: 9354168 DOI: 10.1002/(SICI)1096-9098(199710)66:2<122:: AID-JSO9>3.0.CO;2-F]
27. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007; 245: 36-43 [PMID: 17197963 DOI: 10.1097/01.sla.0000231758.07868.71]
28. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-350 [PMID: 2996162]
29. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252-259 [PMID: 16041216 DOI: 10.1097/01.sla.0000171307.37401.db]
30. Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg 2006; 244: 194-203 [PMID: 16858181 DOI: 10.1097/01.sla.0000225095.18754.45]
31. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL. Anterior approach for difficult major right hepatectomy. World J Surg 1996; 20: 314-317; discussion 318 [PMID: 8661837 DOI: 10.1007/s002689900050]
32. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001; 193: 109-111 [PMID: 11442247 DOI: 10.1016/S1072-7515(01)00909-7]
33. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004; 127: S248-S260 [PMID: 15508091 DOI: 10.1053/j.gastro.2004.09.039]
34. Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev 2009; (1): CD001199 [PMID: 19160192]
35. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC, Naveau S. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17: 1247-1261 [PMID: 12755838]
36. Lau WY, Lai EC, Leung TW, Yu SC. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 2008; 247: 43-48 [PMID: 18156922]
37. Partensky C, Sassolas G, Henry L, Paliard P, Maddern GJ. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study. Arch Surg 2000; 135: 1298-1300 [PMID: 11074884 DOI: 10.1001/archsurg.135.11.1298]
38. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 356: 802-807 [PMID: 11022927 DOI: 10.1016/S0140-6736(00)02654-4]
39. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Kinoshita H. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 2002; 89: 418-422 [PMID: 11952580 DOI: 10.1046/j.0007-1323.2001.02054.x]
40. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, Capussotti L, Calise F, Pellicci R, Belli G, Tagger A, Colombo M, Bonino F, Majno P, Llovet JM. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006; 44: 1543-1554 [PMID: 17133492 DOI: 10.1002/hep.21415]
41. Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Eur J Surg Oncol 2012; 38: 683-691 [PMID: 22621971 DOI: 10.1016/j.ejso.2012.04.010]
42. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012; 308: 1906-1914 [PMID: 23162861 DOI: 10.1001/2012.jama.11975]
43. Tsujita E, Yamashita Y, Takeishi K, Matsuyama A, Tsutsui S, Matsuda H, Toshima T, Taketomi A, Shirabe K, Ishida T, Maehara Y. Poor prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma in the modern era. Am Surg 2012; 78: 419-425 [PMID: 22472398]
44. Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M, Imamura M. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 1998; 5: 86-92 [PMID: 9683759 DOI: 10.1007/PL00009956]
45. Can MF, Hughes CB. Primary liver transplantation vs liver resection followed by transplantation for transplantable hepatocellular carcinoma: Liver functional quality and tumor characteristics matter. World J Gastrointest Surg 2013; 5: 5-8 [PMID: 23515236 DOI: 10.4240/wjgs.v5.i1.5]
46. Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 2012; 55: 132-140 [PMID: 21932387 DOI: 10.1002/hep.24680]
47. Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, Joh JW, Park CK. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: longterm results and prognostic factors. Ann Surg Oncol 2007; 14: 2319-2329 [PMID: 17522947 DOI: 10.1245/s10434-006-9220-8]
48. Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 2005; 92: 1393-1398 [PMID: 16044409 DOI: 10.1002/bjs.5102]
49. Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262: 689-700 [PMID: 22157201 DOI: 10.1148/radiol.11110637]
50. Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a metaanalysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 2013; 25: 187-194 [PMID: 23134976 DOI: 10.1097/MEG.0b013e32835a0a07]
51. Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, Mano Y, Kayashima H, Sugimachi K, Aishima S, Yamashita Y, Ikegami T, Gion T, Uchiyama H, Soejima Y, Maeda T, Shirabe K, Maehara Y. Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2010; 17: 2740-2746 [PMID: 20411432 DOI: 10.1245/s10434-010-1076-2]
52. Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 2007; 141: 196-202 [PMID: 17263976 DOI: 10.1016/j.surg.2006.06.033]
53. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998; 85: 1198-1200 [PMID: 9752858 DOI: 10.1046/j.1365-2168.1998.00846.x]
54. Momoi H, Shimahara Y, Terajima H, Iimuro Y, Yamamoto N, Yamamoto Y, Ikai I, Yamaoka Y. Management of adrenal metastasis from hepatocellular carcinoma. Surg Today 2002; 32: 1035-1041 [PMID: 12541019 DOI: 10.1007/s005950200210]
55. Hashimoto M, Sasaki K, Moriyama J, Matsuda M, Watanabe G. Resection of peritoneal metastases in patients with hepatocellular carcinoma. Surgery 2013; 153: 727-731 [PMID: 22705249 DOI: 10.1016/j.surg.2012.03.031]
56. Kow AW, Kwon CH, Song S, Shin M, Kim JM, Joh JW. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol 2012; 19: 2246-2255 [PMID: 22402812 DOI: 10.1245/s10434-012-2260-3]